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Abstract
Photochemical switches represent a powerful method for improving pharmacological therapies 
and controlling cellular physiology. Here we report the photo-regulation of GABAA receptors 
(GABAARs) by a derivative of propofol (2,6-diisopropylphenol), a GABAAR allosteric 
modulator, that we have modified to contain photo-isomerizable azobenzene. Using α1β2γ2 
GABAARs expressed in Xenopus laevis oocytes and native GABAARs of isolated retinal ganglion 
cells, we show that the trans-azobenzene isomer of the new compound (trans-MPC088), 
generated by visible light (wavelengths ~440 nm), potentiates the GABA-elicited response and at 
higher concentrations directly activates the receptors. cis-MPC088, generated from trans-MPC088 
by UV light (~365 nm), produces little if any receptor potentiation/activation. In cerebellar slices, 
MPC088 co-applied with GABA affords bidirectional photo-modulation of Purkinje cell 
membrane current and spike-firing rate. The findings demonstrate photo-control of GABAARs by 
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an allosteric ligand and open new avenues for fundamental and clinically oriented research on 
GABAARs, a major class of neurotransmitter receptors in the central nervous system.
INTRODUCTION
Synthetically modifying the neurotransmitter agonist of a postsynaptic receptor to contain a 
chemical photoswitch has been shown to afford photo-control of ionotropic receptors for 
acetylcholine and L-glutamate, through regulation of the access of the neurotransmitter 
moiety to its binding site1,2. A different approach is to engineer photo-regulation through a 
modulator rather than an agonist, by perturbing the receptor structure at a site distinct from 
the neurotransmitter binding pocket. The abundance and diversity of known allosteric 
modulators of receptor proteins suggest the feasibility of this alternative approach. Given 
that receptor modulators typically act in concert with endogenous signals in a neural 
network, a photo-switchable modulator could potentially enable relatively subtle conditional 
control of neuronal excitability.
GABAARs are pentameric ligand-gated ion channels that function as postsynaptic and 
extrasynaptic receptors for the inhibitory neurotransmitter γ-aminobutyric acid (GABA) in 
the brain and retina3-5. The α1β2γ2 GABAAR, which consists of two α1 subunits, two β2 
subunits and a single γ2 subunit, is among the most abundant and widely distributed of this 
receptor type. A number of naturally occurring and synthetic low-molecular weight 
compounds are known to modulate the α1β2γ2 GABAAR response to GABA3. Among the 
most extensively studied GABAAR modulators is propofol (Fig. 1a), a nonvolatile 
anesthetic that allosterically potentiates the GABA response and at high concentrations 
directly activates the receptor6-12. Behavioral studies indicate that propofol exerts its 
anesthetic actions by modulating GABAARs13,14. With the aim of developing photo-
regulated α1β2γ2 GABAAR-directed ligands, we have investigated propofol derivatives that 
contain azobenzene, a widely studied photoisomerizable chemical residue capable of bi-
directional switching between trans and cis geometrical isomers1,2,15-20. Here we describe 
the development of a compound, termed MPC088 (Fig. 1a), that displays robust light-
regulated activity at GABAARs. To our knowledge, the present study is the first to report 
photo-control of a neurotransmitter receptor by a cis-trans photoisomerizable compound 
derived from an allosteric ligand. The findings establish a new modality by which to 
regulate GABAARs, a receptor type of major importance to CNS function.
RESULTS
Light-regulated potentiation of α1β2γ2 GABAAR activity
Chemical synthesis and purification yielded MPC088 preparations consisting of the trans- 
and cis-isomers in proportions that were trans-dominant (typically, about 95%) 
(Supplementary Methods). Spectrophotometric and NMR data indicated that, as with 
unmodified azobenzene, UV light (wavelengths near 365 nm) isomerizes the trans-isomer 
MPC088 to the cis form that is stable for many hours in darkness, and visible (or blue) light 
(containing wavelengths near 440 nm) drives cis to trans isomerization (Supplementary 
Note 1 and Supplementary Figs. S1-S2).
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In Xenopus oocytes expressing α1β2γ2 GABAARs, 3 μM GABA elicits a response ~4-10% 
of the saturation level, and was used to test for response enhancement by MPC088. When 
co-applied with 3 μM GABA, MPC088 in predominantly the trans-isomer form increased 
the response in a concentration-dependent fashion (Fig. 1b) and exhibited a potency ~25 
times that of propofol, as determined by the relationship of the MPC088 vs. propofol 
concentration for which the peak response amplitude was 50% of that elicited by 100 μM 
GABA alone (Fig. 1c). By analogy with the known effects of propofol, this action of 
MPC088 could reflect contributions from both potentiation of the GABA response and 
direct receptor activation (i.e., direct agonist activity). We tested for potentiation by 
MPC088 at a concentration (1 μM) associated with negligible direct activation, and 
specifically investigated the effect of light that isomerizes the azobenzene moiety (Figs. 1d-
e). Co-applied 3 μM GABA and 1 μM trans-dominant MPC088 markedly potentiated the 
GABA response, and brief UV illumination presented during static bathing of the oocyte 
decreased the membrane current to a level near that elicited by GABA alone (Supplementary 
Note 2). This level of current was maintained in the ambient light after cessation of the UV 
illumination and, conversely, was increased by exposure to high-intensity visible light. The 
resumption of perfusion with co-applied GABA and trans-dominant MPC088 restored the 
membrane current to a level near that exhibited on initial presentation of the two 
compounds. By contrast, MPD021 (Fig. 1a) that lacks the propofol moiety showed no 
potentiation of the GABA response and failed to inhibit potentiation by MPC088 
(Supplementary Note 3).
Light-regulated direct activation of α1β2γ2 GABAARs
In addition to potentiation, trans-dominant MPC088 robustly activated α1β2γ2 GABAARs 
(Fig. 2). The response elicited by trans-dominant MPC088 was graded with concentration, 
evident at concentrations as low as 4 μM (Figs. 2a-b), and greater than the response to a 
matched concentration of cis-dominant MPC088. The maximum current generated by trans-
dominant MPC088 was comparable with the peak current elicited by 100 μM GABA, while 
that generated by propofol represented only about 40% of the 100 μM GABA response. The 
potency of trans-dominant MPC088 exceeded that of propofol by ~25-fold, as determined 
by the concentrations of MPC088 vs. propofol required for a peak current equal to 40% of 
the 100 μM GABA-alone response (Fig. 2b). The MPC088-elicited response was eliminated 
by the GABAAR channel blocker picrotoxin (PTX)21, but was not sensitive to gabazine 
(SR-95531) – a competitive GABA antagonist22,23 – and was only partially antagonized by 
bicuculline8,24 (Fig. 2b inset). These properties, which are shared by the known GABAAR 
allosteric activators alphaxalone10,22 and pentobarbital24,25, suggested that MPC088 
activates the receptors by binding at a site distinct from the GABA-binding site. UV 
illumination presented during static bathing reduced the MPC088-elicited current, and 
visible light reversed the effect of UV exposure (Figs. 2c-d). Furthermore, repeated pulses of 
UV light presented on a background of continuous visible light during MPC088 treatment 
yielded cyclic changes in response amplitude (Fig. 2e). Together, the data of Figures 1-2 do 
not rule out an action of cis-MPC088 in receptor potentiation or direct activation 
(Supplementary Note 4), but indicate that any such activity is much weaker than that of the 
trans-isomer.
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Activity at GABAARs of differing subunit composition
Propofol is known to modulate GABAA receptors that contain a β subunit. To determine 
whether trans-MPC088 is active at other β-containing GABAA subtypes, we tested the 
compound in oocytes-expressing α1β3γ2, a GABAAR that like α1β2γ2, is widely expressed 
in CNS neurons3,26-28; and at α4β3δ, a subtype that is typically expressed extrasynaptically 
and exhibits high sensitivity to GABA3,5,29. Trans-dominant MPC088 showed potentiating 
activity on both receptor types (Fig. 3a), and this activity was reduced by UV illumination 
(not shown). With co-applied 3 μM GABA (representing ~EC8), the α1β3γ2 GABAAR 
response function obtained with trans-dominant MPC088 closely resembled that determined 
for the α1β2γ2 subtype. By contrast, the trans-MPC088 response function obtained for α4β3δ 
with co-applied 50 nM GABA (~EC8) approached a plateau representing ~42% of the 
response amplitude obtained with high GABA concentration. The low plateau level of the 
α4β3δ response to trans-MPC088 did not reflect a general insensitivity to propofol-based 
compounds, since co-applied 200 μM propofol and 50 nM GABA yielded a response 
representing 1.2 ± 0.1-fold (n = 4) that of the saturating GABA-alone response. In addition, 
the direct agonist activity of trans-MPC088 at α4β3δ was much lower than those at α1β3γ2 
and α1β2γ2 (Fig. 3b). Thus, trans-MPC088, like propofol, modulates multiple types of β-
containing GABAA receptors, albeit with different efficacy. We also tested the activity of 
trans-dominant MPC088 at receptors containing the β-subunit substitution N265M, a 
mutation that markedly reduces the action of propofol both in vitro and in vivo13,30. These 
experiments specifically involved comparison of the normalized responses of α1β3γ2 and 
α1β3(N265M)γ2 GABAARs to trans-MPC088 (1 μM) and co-applied GABA. Response 
enhancement by trans-MPC088 was substantial at both receptor types, but that for 
α1β3(N265M)γ2 (2.9 ± 0.8-fold, n=4) was significantly smaller than that for the wildtype 
α1β3γ2 (4.4 ± 1.3-fold, n=5; p=0.03, two-sample t-test) (Supplementary Fig. S3). Like 
propofol, trans-MPC088 lacked both potentiating and direct agonist activity on oocytes 
expressing the GABAAR subtype that consists of a pentameric assembly of ρ1 subunits31.
Receptor-tethered MPC088 analog
MPC088 is a freely diffusible compound and can be removed by superfusion of the oocyte 
with Ringer. We asked whether covalent tethering of a similar compound to a suitably 
modified receptor produces persistent potentiation and/or activation. MPC100 (Fig. 1a), 
prepared by coupling a maleimide-terminated 24-mer poly(ethylene glycol) (PEG) linker to 
the free amino group of MPC088, was tested on oocytes expressing a cysteine substitution at 
position 79 of the single γ subunit of α1β2γ2 [α1β2γ2(A79C)]32,33, abbreviated as γ-79C. The 
thiol group of the cysteine residue allowed covalent anchoring of MPC10015,17,19. Oocytes 
expressing γ-79C GABAARs, following incubation with trans-dominant MPC100 and then 
superfusion with unsupplemented Ringer to remove untethered compound, exhibited 
persistent potentiation of the GABA response (Figs. 4a-b), which was sensitive to UV and 
visible light (Fig. 4c). These effects of illumination resembled those displayed by wildtype 
α1β2γ2 GABAAR-expressing oocytes in the presence of co-applied GABA and MPC088 
(compare Figs. 1d and 4c), although the extent of UV-induced de-potentiation observed with 
the tethered MPC100 was less than that determined on similar treatment with (diffusible) 
MPC088. The smaller excursion of de-potentiation likely resulted from the inability of the 
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UV stimulating light, which was delivered from above the (opaque) oocyte, to efficiently 
access MPC100 tethered to the lower, approximately hemispherical surface of the cell.
Treatment of γ-79C-expressing oocytes with trans-dominant MPC100 led to a greater (i.e., 
more negative) baseline current, and UV illumination produced an opposite change (Fig. 4c; 
note the relationship of the dotted reference lines i and ii). To test whether the baseline 
change reflected continuing, direct activation by the tethered MPC100 in the absence of 
GABA, we investigated the effect of PTX presented before and after MPC100 treatment. 
PTX application to MPC100-treated and then washed cells reversibly reduced the baseline 
current by 85 ± 7% (n = 5) (Fig. 4d, traces i-ii). UV (i.e., cis-generating) illumination 
delivered during PTX treatment did not further reduce the baseline amplitude, but inhibited 
baseline recovery following PTX removal, consistent with a UV-induced reduction in the 
amount of trans-MPC100 present (Fig. 4d, trace iii). Furthermore, UV and visible light 
delivered to MPC100-treated γ-79C-expressing oocytes produced, respectively, decreases 
and increases in membrane current qualitatively similar to those exhibited by wildtype 
α1β2γ2 GABAARs in the presence of trans-MPC088 alone (Figs. 4e-f). Thus, the larger 
baseline current persisting after MPC100 treatment (Fig. 4c) reflected sustained, direct 
activation of the receptor by tethered trans-MPC100.
These persistent effects of MPC100 required the γ-79C modification. While MPC100 
exhibited potentiation on wildtype α1β2γ2 GABAARs (albeit to an extent less than that 
exhibited by MPC088), this effect was eliminated by Ringer perfusion (Supplementary Note 
5 and Supplementary Fig. S4). In addition, on γ-79C-expressing oocytes, pre-treatment with 
the thiol-reactive compound methyl-(PEG)11-maleimide blocked the activity of 
subsequently applied MPC100 (Supplementary Note 6). These findings indicate a 
dependence of MPC100’s persistent activity on tethering specifically at the engineered 
cysteine site of the γ-79C receptor.
Activity at GABAARs of retinal ganglion cells
To test whether native neuronal GABAARs respond to MPC088, we examined retinal 
ganglion cells (RGCs), a cell type known to abundantly express GABAARs34-37. When 
presented to single dissociated RGCs of rat retina, 10 μM trans-dominant MPC088 
produced, on average, an approximately 5-fold potentiation of the response elicited by 2 μM 
GABA, while cis-dominant MPC088 exhibited much less potentiation activity (Fig. 5a). At 
30 μM, trans-dominant MPC088 alone produced a membrane current response whose peak 
amplitude amounted, on average, to 5% of the cell’s response to 200 μM GABA (Fig. 5b, 
inset). However, at 60 μM, the agonist effect increased to 43 ± 9% of the response to 200 
μM GABA (n = 7), and pre-treatment of trans-dominant MPC088 with UV light reduced 
this agonist activity by 88 ± 6% (n = 4; p = 0.002, two-sample t-test) (Fig. 5b). Co-
application of 100 μM PTX virtually eliminated the ganglion cell response to 2 μM GABA + 
10 μM trans-dominant MPC088, and to 60 μM trans-dominant MPC088 alone 
(Supplementary Note 7 and Supplementary Fig. S5), consistent with mediation of trans-
MPC088’s potentiation and direct activation by GABAARs.
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Photo-regulation of GABAARs of cerebellar Purkinje neurons
To evaluate the efficacy of MPC088 in GABAAR-expressing cells in situ, we conducted 
whole-cell voltage-clamp experiments on Purkinje neurons (PNs) in parasagittal slices from 
mouse cerebellum38,39 (Fig. 6 and Supplementary Methods). PNs are known to express 
GABAARs of the α1β2/3γ2 forms26-28. Figure 6a shows the experimental setup, indicating 
how blue and UV light sources were combined in the epifluorescence pathway of an upright 
microscope. Currents were evoked in the PNs by applying 10 μM GABA from a local 
pressure pipette that also contained 30 μM trans-dominant MPC088. UV illumination during 
the elicited response markedly decreased the membrane current; conversely, blue light 
enhanced the current (Fig. 6b). To determine whether these effects of light required the 
presence of MPC088, we performed similar experiments on the same cell by replacing the 
pressure pipette with one that contained only GABA (Fig. 6c) or GABA plus propofol (Fig. 
6d). By contrast with the Figure 6b results, there was little or no light-induced current 
change under either condition. To quantify these results, we measured the current change in 
response to transitions from UV to blue light and from blue to UV light (Fig. 6e). We found 
that the current changes produced by these transitions were opposite and, on average, equal 
in magnitude (mean ratio of absolute current magnitude in response to blue→UV / 
UV→blue was 1.00 ± 0.01, a value that did not differ significantly from unity; p = 0.86; 
one-sample t-test, n = 7) (Fig. 6f). Together, these results demonstrate that MPC088 directly 
modulates GABAARs of cerebellar PNs in situ.
We also examined the effects of MPC088 on action potential firing in PNs of the cerebellar 
slice. These experiments were similar to those described above, except that the cells were 
recorded under current-clamp in order to allow the cell to spike. To each of the PNs 
described in Figures 7a-b, we first delivered GABA (10 μM) plus trans-dominant MPC088 
(30 μM) by pressure application, and then exposed the cell to sequences of UV-Blue-UV 
light. Exposure to GABA + trans-dominant MPC088 decreased the firing rate by 
approximately 50%, on average (Fig. 7b). Furthermore, in all of the 8 investigated cells, the 
UV-Blue-UV flash sequence led, respectively, to an increase, decrease and increase in firing 
rate. Overall, the firing rate produced by blue light was 52 ± 14% of that produced by UV 
light. In 3 of the 8 PNs, blue light decreased the firing rate to <20% of that exhibited during 
the UV illumination, and one PN exhibited a blue-light-induced complete cessation of 
spiking that was reversed by subsequent UV. As a negative control, we exposed cells to the 
UV-Blue-UV light sequence but in the absence of GABA/MPC088 application. In these 
cells, there was no significant change in firing rate with any of the light flashes (Fig. 7c). 
Together, these data indicate a reversible, light-dependent action of MPC088 on PN spike-
firing rate.
To test for direct agonist activity of MPC088 on PNs, we perfused cerebellar slices with 
recirculating 30 μM MPC088 (the maximal MPC088 concentration we could reliably 
maintain solubilized in bicarbonate-buffered solution). MPC088 was converted to cis-
dominant form by a 2-min exposure to UV light (LED, 365 nm/160 mW, Mouser, Inc., 
Mansfield, TX; LED driver, 700 mA BuckPuck DC Driver, Quadica Developments, Inc., 
Brantford, Ontario, Canada), before its dilution into the recirculating external solution. The 
same LED was then used to continuously UV-illuminate the recirculating solution for the 
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duration of the experiment. We then obtained whole-cell voltage clamp recordings from PNs 
and determined the change in membrane current produced by alternating blue and UV 
illumination of the slice, as in the Figure 6 experiments. Of 44 cells examined, only 28 
exhibited a current change >18 pA, which is the average amplitude of the Blue-to-UV light 
currents from the vehicle and propofol conditions described in Figure 6. The average 
response from this subset of 28 cells was 80 ± 13 pA. We then sought to test whether these 
currents were due to an agonist action of the drug, as opposed to a modulatory action 
occurring in concert with low levels of endogenous GABA present in the slice40. To discern 
modulation, we analyzed the effect of added 30 μM gabazine22,23, a condition expected to 
inhibit the potentiating action of MPC088 (i.e., to inhibit response enhancement dependent 
on endogenous GABA) but not to affect the direct agonist activity of MPC088 (Fig. 2). In 
all but one of eight cells that exhibited light-evoked responses of >50 pA to the Blue-to-UV 
switch, gabazine (30 μM) reduced the current to below the vehicle level of 18 pA (Fig. 8a-
b). The average current remaining after gabazine treatment represented 11 ± 3 % of the pre-
gabazine current (Fig. 8b). Even for the cell exhibiting the highest response of the 44 cells 
tested, gabazine completely abolished the response (Fig. 8a). Thus, at concentrations 
comparable to or lower than 30 μM, trans-MPC088 in cerebellar tissue is modulatory 
(endogenous GABA-dependent) rather than agonistic.
Specificity of MPC088 for GABAARs on neurons
To further address whether MPC088 has non-specific effects on excitability, we analyzed 
the spikes elicited in the experiment described in Figure 7. We examined spikes recorded 
during exposure to GABA/MPC088 (“puff”) and under conditions in which MPC088 was 
absent but in which the Purkinje cell received the UV/Blue/UV light sequence (“no-puff”). 
Three action potential (AP) parameters were measured: peak amplitude, half width, and 
maximum rise slope. Parameters were obtained from spikes occurring in the same 1-s 
epochs in which average firing rate was significantly modulated by MPC088 (see Fig. 7b-c). 
AP waveform parameters were calculated for pre-puff, blue light, and UV epochs. Average 
values in the pre-treatment epochs for puff and no-puff did not significantly differ (Spike 
Amplitude (mV), 52 ± 2 and 51 ± 2; Half Width (ms), 0.61 ± 0.03 and 0.57 ± 0.03; 
Maximum Rise Slope (mV/ms), 150 ± 10 and 161 ± 13; p>0.4, unpaired t-test). In addition, 
for each parameter, we normalized the average values for each cell and for each epoch, to 
the averages in the pre-treatment epochs (pre-puff, pre-light). This analysis of excitability 
showed first, that the only measureable effects on AP waveform are MPC088-independent 
and caused by light exposure, and second, that the effect size of light is extremely small 
(less than 2%; Supplementary Fig. S6 and Supplementary Note 8).
To test whether MPC088 affects excitatory synaptic transmission, we carried out whole-cell 
voltage-clamp recordings in CA1 pyramidal neurons of mouse hippocampus. As in the 
experiments of Figure 8, these recordings were obtained with perfusion of the slice with cis-
dominant MPC088 (30 μM) under recirculation. PTX (100μM) was also included in the 
external solution to block GABAARs. We evoked EPSCs by stimulating the Schaffer 
collaterals with a bipolar matrix microelectrode (FHC, Inc., Bowdoin, ME), and recorded at 
a holding potential of +40 mV to uncover the NMDA receptor (NMDAR) component of the 
EPSC. We also presented paired electrical stimuli separated by 80 ms to assess possible 
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effects of MPC088 on short-term plasticity. Each cell was given 20 interleaved trials in 
which the cell was exposed to two 0.1-s UV pulses surrounding a 1-s period of either blue 
light or no light (Supplementary Fig. S7 and Supplementary Methods). The effectiveness of 
the 0.1-s UV and the 1-s blue stimuli in photoconverting MPC088 was confirmed in separate 
experiments using 30 μM MPC088 and 3 μM GABA on the same preparation. To quantify 
the effects of MPC088 on AMPA receptors (AMPARs) and NMDARs, we measured, for the 
first EPSC of the pair, the peak current and the current just prior to the second stimulus, 
which reflect AMPAR and NMDAR components, respectively, of the EPSC41. Neither 
AMPAR-mediated nor NMDAR-mediated components of the EPSC were significantly 
altered by blue light (Supplementary Fig. S7b). Additionally, blue light had no significant 
effect on the decay of the compound current (average τ from single-exponential fitting to the 
decay of the second EPSC: Blue off, 131 ± 11 ms; Blue on, 131 ± 11 ms; p=0.89, paired t-
test). There was also no significant effect of blue light on the paired-pulse ratio (PPR, 
measured as Peak(2nd EPSC)/Peak(1st EPSC): Blue off, 1.72 ± 0.07; Blue on, 1.85 ± 0.14; 
p=0.34, paired t-test). Together, these results indicate that MPC088 does not significantly 
affect presynaptic function and that it has negligible actions on AMPAR-mediated and 
NMDAR-mediated EPSCs.
DISCUSSION
The results demonstrate that MPC088, a photoisomerizable compound derived from the 
allosteric ligand propofol, exerts a highly potent and light-sensitive regulation of GABAA 
receptors. Light of differing wavelength can reversibly and in a quasi-stable manner inter-
convert the relatively active and inactive isomers of MPC088; this distinguishes the 
compound from a photosensitive ligand in which light activates the ligand by excitation of a 
fluorescent moiety42 or by irreversibly eliminating a protective (caging) structural 
component. In addition to conferring pronounced light-sensitivity to the receptor, MPC088 
in its active (trans) form exhibits a potency considerably exceeding that of propofol itself. 
Our data indicate that the propofol moiety is required for activity, but it remains to be 
determined whether the high potency of MPC088 is due in addition to specific receptor-
binding interactions with the butyryl, azobenzene and/or ethylenediamine moieties of the 
compound. Such a possibility is consistent with the finding that the α1β3(N265M)γ2 
GABAAR, which contains a substitution that strongly decreases the in vivo action of 
propofol13, exhibits reduced but still substantial sensitivity to trans-MPC088. Furthermore, 
while the present results argue against a direct agonist action of trans-MPC088 on ligand-
gated ion channels of cerebellar PNs other than GABAARs, the broad possibility remains 
that trans-MPC088 has physiological effects on non-GABAAR ion channels or other surface 
proteins of neural tissue. Particularly at higher concentrations, some broader activity of the 
compound would likely be tolerable, as propofol itself, while most active at GABAARs14, is 
known to have effects on other cellular targets43.
We have also examined the properties of MPC100, a tetherable derivative of MPC088 that, 
via its terminating maleimide group, covalently binds to the cysteine-substituted γ-79C 
mutant form of the α1β2γ2 GABAAR. The tethered compound exhibits persistent, light-
regulated potentiating and activating effects on GABAARs. Thus, the tetherable MPC100 
may have application in approaches that involve neuronal expression of a genetically 
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engineered α1β2γ2 GABAAR to which the photoswitch could be anchored, as in previous 
studies of potassium channels and L-glutamate receptors15,17,19. Furthermore, by contrast 
with previous structures designed for photo-control of transmembrane ion channels1,15,17,19, 
a relatively long linear chain (PEG24) separates the regulating structure (MPC088 moiety) 
from the tethering moiety (maleimide). Beyond demonstrating that a long and flexible 
hydrophilic linker (and resultant high conformational entropy) can preserve substantial 
physiological activity of the distal MPC088 moiety, properties exhibited by MPC100 
suggest the potential workability of other remote locations on the GABAAR itself for 
modulator attachment, or conjugation of the modulator to an affinity reagent designed for 
binding to the extracellular domain of the native GABAAR. As a general route to controlling 
neuronal activity with a modulating ligand, covalent binding of an introduced reactive (e.g., 
maleimide-terminated) ligand to an engineered receptor site offers the advantage, in 
principle, of defining the precise receptor subtype4 on which the ligand will act. However 
this approach presents possible challenges relating to the need for inducing expression of the 
engineered receptor in the target cell type, and for avoiding problematic binding of the 
reactive ligand to unintended sites (e.g., other cysteine-containing surface proteins) on both 
the target cells and others.
The wide distribution of α1β2γ2 GABAARs in central nervous system (CNS) tissues and the 
clinical importance of propofol encourage the investigation of MPC088 as a 
pharmacological tool in studies of CNS neural circuits. Toward this end we have 
demonstrated that the compound reversibly modulates GABA currents in retinal neurons and 
cerebellar PNs and that it can be used to reversibly control spiking output of PNs. Given that 
PNs are intrinsically active at constant rates38,39, they are useful for examining this 
modulation because their spike rate gives a continuous readout of excitability.
In providing the ability to control circuit excitability with spatial and temporal precision, 
switchable modulators of neural activity open new possibilities for exploring the links 
between neuronal activity and behavior. For example, MPC088 and related diffusible 
compounds could allow regional induction of anesthesia through the use of implanted 
optical fibers or a head-fixed preparation. This approach could be used to explore which 
brain regions are most important for anesthesia and sedation. Clinical contexts in which a 
photo-switchable GABAAR modulator might be useful include diseases of hyperexcitability, 
such as epilepsy44-47. Propofol is known to be an effective therapeutic for intractable 
epilepsy, although side effects are a concern48-50. Photo-switchable propofol analogs, in 
combination with localized optical stimulation51 and appropriate electrical monitoring, 
might enable a reduction of side effects in treating epilepsies, by employing spatially 
precise, optically-regulated receptor modulation specifically during bouts of 
hyperexcitability. Furthermore, even with a diffusible modulator, focally directed 
illumination could allow spatially restricted actions of the anti-epileptic drug around seizure 
foci.
The photosensitivity and potency of MPC088 raise the possibility that compounds of this 
type might be used therapeutically in visual disorders. GABAARs are known to mediate 
visual signaling at multiple sites within the retina34,35,37,52-54; GABAARs of retinal bipolar 
and ganglion cells are sensitive to propofol55,56; and, as in oocyte-expressed α1β2γ2 
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GABAARs, responses of retinal ganglion cells are potentiated and directly activated 
specifically by the trans -isomer of MPC088 (Fig. 5). In diseases involving degeneration of 
the retina’s rod and cone photoreceptors, MPC088-inspired constructs of optimized 
wavelength sensitivity and relaxation kinetics57, and containing an affinity reagent-based 
anchor to provide cell-targeting specificity, may have application as a vision restoration 
therapy, by establishing a photosensitivity of inner retinal neurons that effectively bypasses 
the dysfunctional rods and cones.
METHODS
Electrophysiological recordings
Electrophysiological experiments were conducted on Xenopus laevis oocytes expressing 
α1β2γ2 GABAARs (rat α1, rat β2 and human γ2S); on single, isolated ganglion cells of rat 
retina; on Purkinje neurons (PNs) in acute slice preparations of mouse cerebellum; and on 
CA1 neurons in acute slice preparations of mouse hippocampus. Animal care and all 
procedures involving the use of animals were conducted in accordance with institutional 
policies of the University of Illinois at Chicago (for Xenopus laevis and rats), and with the 
approval of the Chancellor’s Animal Research Committee (Institutional Animal Care and 
Use Committee) at the University of California, Los Angeles (for mice).
Xenopus laevis oocytes
Oocytes expressing α1β2γ2 receptors (rat α1, rat β2 and human γ2S) were prepared and 
studied by two-electrode voltage-clamp recording58 (holding potential: -70 mV; amplifier: 
GeneClamp500B; Axon Instruments, Foster City, CA). Unless otherwise indicated, oocytes 
were superfused with Ringer solution (physiological saline) at a rate of ~1mL/min. The 
experiments of Figures 1d-e, 2c-e and S4 involved periods of static bathing, i.e., halted 
superfusion. The γ2(A79C) subunit was prepared by site-directed mutagenesis. Oocyte 
electrophysiological experiments were carried out in room light. A UV light-emitting diode 
(peak wavelength: 365 nm; Hamamatsu Photonics, Japan) and a microscope illuminator 
(white light; Schott Fostec, Auburn, NY) provided UV and visible stimulating light. As 
measured at the position of the oocyte, the intensity of the UV light at 365 nm was 220 
μW/mm2. At 440 nm, the nominal strength of the visible (white) light (referred to as high-
intensity visible light) was 28 μW/mm2, and that of the ambient room illumination was 
0.045 μW/mm2. In all experiments, low-intensity visible light from the microscope 
illuminator (3 μW/mm2 at 440 nm) was present at all times except those involving high-
intensity visible illumination. Electrophysiological data were obtained using Clampex 8.2 
(Axon Instruments), analyzed using Clampfit 10.0 (Axon Instruments) and OriginPro7.5 
(OriginLab, Northampton, MA).
Retinal ganglion cells of rat
Experiments were conducted on enzymatically dissociated ganglion cells obtained from 
adult Sprague-Dawley rats (male and female, 6-16 weeks of age) (Charles River 
Laboratories, Wilmington, MA). Procedures for euthanasia, isolation of the retina, and the 
dissociation of retinal cells were as described previously59 except that the period of retinal 
cell dissociation was shortened from 40 min to 20 min. Isolated ganglion cells were 
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identified on the basis of their morphological appearance and the presence of a large 
voltage-gated sodium current. Whole-cell patch-clamp techniques similar to those 
described59 were used to record membrane current responses to test agents. The patch 
pipette with a resistance of 8-12 MΩ was pulled in two stages using a micro-electrode puller 
(Model PP830, Narishige Group, Tokyo, Japan). The pipette was filled with an intracellular 
solution containing 95 mM CsCH3SO3, 20 mM TEA-Cl, 10 mM glutamic acid, 1 mM 
BAPTA, 10 mM HEPES, 8 mM phosphocreatine di(tris), 1 mM MgATP and 0.2 mM 
Na2GTP; pH adjusted to 7.2 with CsOH. Cells were clamped at 0 mV (Axopatch 200B 
amplifier; Axon Instruments), and experimental runs were controlled by pCLAMP system 
software (Axon Instruments). Electrophysiological data were obtained in response to test 
compounds dissolved in physiological saline (Ringer solution) that consisted of 135 mM 
NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM glucose, and 5 mM HEPES, pH 7.4. 
Supplementation of aqueous test solutions with MPC088 was carried out by adding an 
aliquot of a stock solution containing the compound dissolved in dimethyl sulfoxide 
(DMSO). In all experiments, the amount of carrier DMSO present in the applied test 
solution was <1% (v/v). Test solutions were delivered from separate reservoirs by a multi-
channel perfusion system. The same UV-LED used in the oocyte experiments was used for 
UV illumination of MPC088-supplemented test solutions. For preparation of cis-dominant 
MPC088, the test solution of initially trans-dominant compound underwent a 5-min UV 
illumination prior to its placement in the perfusion reservoir. All preparative procedures 
were performed in the dark, and the reservoirs and perfusion lines were light-protected with 
aluminum foil. As in the oocyte experiments, data were analyzed with Clampfit and plotted 
with Origin. Unless otherwise stated, numerical data from replicate experiments are 
presented as mean ± SD, and all statistical analyses of data obtained from oocytes and from 
retinal ganglion cells employed a two-sample t-test.
Cerebellar Purkinje neurons from mice
Experiments on cerebellar PNs employed acute slices obtained from cerebella of 16-30 day-
old C57/BL6 mice (Charles River Laboratories). After induction of deep anesthesia with 
isoflurane, mice were decapitated, and the cerebellum vermis was removed and placed in an 
ice-cold cutting solution containing (in mM): 85 NaCl, 2.5 KCl, 0.5 CaCl2, 4 MgCl2, 1.25 
NaH2PO4, 24 NaHCO3, 25 glucose, and 75 sucrose. A Leica VT1000 vibratome was used to 
cut 250 μm thick, sagittal slices from the cerebellar vermis. Slices were then placed in an 
external recording solution containing (in mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1 
NaH2PO4, 26.2 NaHCO3, and 25 glucose. The solution was warmed to 35°C for 15-20 min 
and then allowed to reach room temperature. Both the cutting solution and the recording 
solution were continuously bubbled with 95% O2 / 5% CO2, and the recording solution was 
perfused at the rate of 2-4 mL/min.
Whole-cell voltage-clamp recordings were carried out at room temperature from PNs with 
an Axopatch 200A amplifier (Axon Instruments), and the neurons were held at -70 mV. 
Recording pipettes had bath resistances of 2-6 MΩ and were pulled using a horizontal 
micropipette puller (Model P-1000 Flaming/Brown Micropipette Puller, Sutter Instrument 
Company, Novato, CA). The internal solution for voltage clamp (Figs. 6 and 8) contained 
(in mM): 140 CsCl, 3 NaCl, 10 HEPES, 2 MgCl2, 4 ATP, 0.4 GTP, 1 EGTA, 10 TEA-Cl 
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and 5 QX-314 Br (to block respectively, Kv and Nav channels), and pH was adjusted to 7.4 
with CsOH. Cs-based internal solutions prevented a small, UV light-elicited, transient 
outward current that was seen in the absence of GABA or MPC088. In some recordings 
CdCl2 (100 μM) was included in the external solution to block synaptic transmission. 
Although we found no differences in the magnitudes of the MPC088-dependent currents, 
this had two benefits; it reduced spontaneous synaptic activity which would otherwise 
appear as high frequency noise on the traces, and it confirmed that MPC088 actions were 
cell-autonomous.
Whole-cell current-clamp recordings from PNs were carried out at room temperature with 
the same equipment as described above. Recording pipettes had bath resistances of 6-9 MΩ. 
The internal solution substituted 126-130 mM KMeSO3 for CsCl/(TEA-Cl) and contained 5 
mM EGTA. In some cases internal solutions for current clamp included 5 mM 
phosphocreatine and KCl substituted for NaCl to yield a final chloride concentration of 14 
mM. Where appropriate, distilled water was added to adjust final osmolarity. In some cases 
positive current was injected into the PNs to elicit spiking. Local drug application to the PNs 
was achieved with a glass pipette (2-3 μm tip diameter) filled with the solution containing 
the indicated compounds dissolved in filtered external recording solution. Pressure pulses 
(0.5 to 2 psi) were provided by a Picospritzer II (Parker Hannifin Co., Cleveland, OH). Data 
from cells were excluded from analysis if there was no detectable decrease in firing rate with 
GABA + MPC088 application. They were also excluded if the average baseline (2-s epoch 
before drug application) firing rates fell outside the range 5 to 100 Hz, or if the cell stopped 
firing completely in the midst of the trial and did not recover by the end of the trial.
Pulses of UV light were presented to the tissue by shuttering a 100 W mercury arc lamp. 
Light from this source was collimated and focused through the objective lens of the 
recording apparatus. The broad-spectrum light from the arc lamp passed through an 
excitation filter (366 nm; full-width at half-maximum, 16.6 nm; Semrock, Inc., Rochester, 
NY) to isolate the UV component, and reflected off a dichroic mirror (409 nm cutoff, 
Semrock, Inc.) (Fig. 6a). The blue light source was a 470 nm LED (Quadica Developments, 
Inc., Brantford, Ontario, Canada) that was connected to a beamsplitter cube (Siskiyou 
Designs, Grants Pass, OR) located in the infinity space above the objective. The blue light 
was reflected by the dichroic mirror (500 nm cutoff, Chroma Technology Co., Bellows 
Falls, VT) positioned in the beamsplitter cube such that it passed through the 409 nm 
dichroic mirror in the UV filter cube to reach the slice. This configuration allowed UV and 
blue light to be combined in the epifluorescence path and independently controlled. To 
minimize exposure of the slice preparation and MPC088-containing solutions to ambient 
room light, the experimental apparatus housing the cerebellar slice, microscope, micro-
manipulators and perfusion lines was shielded by a dark curtain, and a photographic safe-
light was used inside the area housing these components. Illumination from the microscope 
lamp used for visual inspection of the tissue passed through a Wratten 2 29 filter that 
attenuated wavelengths below 600 nm. All data from experiments on PNs are presented as 
mean ± SEM.
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Figure 1. Effect of MPC088 on the 3 μM GABA response of α1β2γ2 GABAAR-expressing oocytes
a: Chemical structures. b: Responses of a single oocyte to co-applied 3 μM GABA and 
varying concentration of trans-dominant MPC088. Horizontal bar indicates the period of 
superfusion with GABA- and MPC088-supplemented Ringer solution. c: Aggregate 
concentration-response data (mean ± SD) describing responses elicited by co-applied 3 μM 
GABA and trans-dominant MPC088 or propofol. Response amplitudes obtained from each 
oocyte normalized to that elicited by 100 μM GABA alone, a near-saturating condition that 
is essentially insensitive to propofol potentiation. MPC088 and propofol results, each 
obtained from 7 oocytes. d: Light-dependent alteration of the 3 μM GABA response by co-
applied, initially trans-dominant, 1 μM MPC088. Black bars: periods of superfusion with co-
applied 3 μM GABA and 1 μM MPC088. Purple and gray bars: period of presentation of 
UV light and high-intensity visible light (High-Vis), respectively. e: Results obtained in the 
experiment of d and 3 others of similar design (mean ± SD). Membrane current amplitudes, 
normalized to the peak amplitude of the 3 μM GABA response, determined under 7 
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sequential conditions: (1) in low-intensity visible light (Low-Vis), at the conclusion of 
superfusion with (3 μM GABA + 1 μM MPC088); (2) at the conclusion of UV illumination; 
(3) in low-intensity visible light; (4) at the conclusion of high-intensity visible illumination; 
(5) at the conclusion of a second UV illumination; (6) at the conclusion of a second high-
intensity visible illumination; and (7) at the conclusion of resumed superfusion with fresh 3 
μM GABA + 1 μM trans-dominant MPC088. These amplitude determination conditions are 
denoted by numbers beneath the waveform in d. Repeated-measures ANOVA conducted on 
the aggregate data yielded F(6,18) = 41.975, p <0.001. Post-hoc paired-sample t-tests 
corrected for multiple comparisons indicated significant differences produced by the initial 
UV, the initial High-Vis, the second UV, and the second High-Vis illuminations (p ≤ 0.009 
for amplitude group 2 vs. group 1, for 4 vs. 3, for 5 vs. 4, and for 6 vs. 5, respectively); 
amplitude groups 7 and 1 did not differ significantly (p = 0.075).
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Figure 2. MPC088 agonist activity in oocytes expressing α1β2γ2 GABAARs
a: Representative responses to MPC088 obtained in a single experiment. b: Concentration-
response functions (mean ± SD) for trans- and cis-dominant MPC088 (n = 6) and propofol 
(n = 6). In each of the MPC088 experiments, the cis-dominant form was generated by UV 
light during static bathing. Amplitudes normalized to the 100 μM GABA response. Inset: 
Sensitivity (mean ± SD) of the MPC088 (15 μM) response to 100 μM PTX (n = 4), 100 μM 
bicuculline (n = 4) and 30 μM gabazine (n = 4). c: Photo-regulation of the response to 15 
μM MPC088. d: Normalized current amplitudes (mean ± SD) determined in the experiment 
of c and in 3 others of similar design. Amplitudes in each experiment normalized to that 
elicited by 3 μM GABA. Numbers beneath the waveform in c denote amplitude 
determination conditions for the experiment shown in c. Repeated-measures ANOVA 
conducted on the aggregate data yielded F(6,18) = 68.988, p < 0.001. Post-hoc paired-
sample t-tests corrected for multiple comparisons indicated significant differences produced 
by the initial UV, the initial High-Vis, the second UV, and the second High-Vis 
illuminations (p ≤ 0.010 for amplitude group 2 vs. group 1, for 4 vs. 3, for 5 vs. 4, and for 6 
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vs. 5, respectively); amplitude groups 7 and 1 did not differ significantly (p = 0.96). e: 
Representative waveform obtained with repeated presentation of UV light during continuous 
High-Vis illumination (static bathing in MPC088-supplemented Ringer).
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Figure 3. Effect of MPC088 on α1β3γ2 and α4β3δ GABAAR-expressing oocytes
Data in each group obtained from 4 oocytes. a: Aggregate concentration-response data 
(mean ± SD) obtained from α1β3γ2 (black) and α4β3δ (red) receptors with co-applied GABA 
at similar ~EC8 dose (i.e., 3 μM for the former and 0.05 μM for the latter receptor type) and 
varying concentrations of trans-dominant MPC088. Response amplitudes obtained from 
each oocyte normalized to its saturating GABA response (i.e., responses obtained with 1,000 
μM GABA for α1β3γ2 and 100 μM GABA for α4β3δ GABAARs). b: Aggregate 
concentration-response data (mean ± SD) obtained from α1β3γ2 (black) and α4β3δ (red) 
receptors with trans-dominant MPC088 alone. Data similarly normalized to the saturating 
GABA response obtained from each oocyte. Results for α1β2γ2 GABAARs in a and b (blue) 
reproduced from those of Figures 1c and 2b, respectively.
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Figure 4. Persistent potentiation and activation by MPC100 in γ-79C-expressing oocytes
a: GABA responses of a single oocyte before (left) and after (right) MPC100 treatment (100 
μM). Right-hand waveforms recorded after ~7-min incubation with MPC100 and subsequent 
Ringer perfusion. b: GABA response functions showing aggregate data (mean ± SD; 5 
oocytes) obtained before MPC100 treatment, and after treatment with 100 μM MPC100 and 
subsequent washout (~5 min). Amplitudes normalized to that elicited by 100 μM GABA 
before MPC100 treatment. c: Light-dependence of persistent potentiation. Black trace: 
response to UV and visible light in the presence of 0.1 μM GABA, following treatment with 
100 μM trans-dominant MPC100. Dotted lines i and ii highlight the difference in baseline 
current before (ii) vs. after (i) UV illumination). Red trace: later phase of the same 
experiment (responses obtained after a further ~1 min Ringer perfusion). d: Baseline 
currents obtained in a single experiment. Trace (i): nominal response to PTX (100 μM). 
Traces ii-iii: PTX responses obtained after treatment with 100 μM MPC100, in the absence 
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(ii) and presence (iii) of UV illumination. e: Responses to UV and visible light following 
exposure to trans-dominant MPC100 and washout (~5 min) of free MPC100. Data obtained 
from a single oocyte. A period of Ringer perfusion (~1 min) separated the initial (black 
trace) and later (red trace) phases of the experiment. f: Aggregate results (mean ± SD) from 
experiment e and 3 others, each involving amplitude determinations under 6 sequential 
experimental conditions. Data normalized to the persisting shift in baseline produced by 
MPC100 treatment. Periods of treatment in each experiment were similar to those illustrated 
in e. Numbers beneath the waveforms in e denote amplitude determination conditions for the 
experiment shown in e. Repeated-measures ANOVA conducted on the aggregate data 
yielded F(6,18) = 65.290, p < 0.001. Post-hoc paired-sample t-tests corrected for multiple 
comparisons indicated significant differences produced by the initial UV, the initial High-
Vis, the second UV, and the second High-Vis illuminations (p ≤ 0.007 for amplitude group 2 
vs. group 1, for 3 vs. 2, for 4 vs. 3, and for 6 vs. 5, respectively).
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Figure 5. Action of MPC088 on retinal ganglion cells
a: Potentiation data obtained with trans- and cis-dominant MPC088; the cis-dominant 
preparation was obtained by pre-treating trans-dominant MPC088 with UV light for 5 min. 
Representative responses obtained from a single cell treated with 200 μM GABA (black), 2 
μM GABA (red), 2 μM GABA co-applied with 10 μM of trans-dominant (blue) or cis-
dominant (magenta) MPC088. Inset: Aggregate data (mean ± SD) for potentiation factor 
determined with trans- and cis-dominant MPC088 (left and right bars, respectively) (n=6, p 
= 0.003). b: Direct activation data obtained with trans- and cis-dominant MPC088. 
Representative responses obtained from a cell treated with 200 μM GABA (black), 60 μM of 
trans-dominant (blue) and 60 μM of cis-dominant (magenta) MPC088. Inset: Aggregate 
data (mean ± SD) for direct activation by MPC088. Left, middle and right bars show results 
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obtained, respectively, with 30 μM trans-dominant (n=3), 60 μM trans-dominant (n=7), and 
60 μM cis-dominant MPC088 (n=4).
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Figure 6. Effect of MPC088 photoactivation on GABA-evoked currents in cerebellar PNs
a: Optical configuration. b: Representative trace from a whole-cell voltage-clamp recording 
from a PN. The cell was held at -70 mV, and 10 μM GABA + 30 μM MPC088 were applied 
via pressure pipette for 30 s. The cell was flashed with UV light (1 s, shuttered from a 
mercury arc lamp), then blue light (1 s, from a 470 nm LED), and then again with UV light 
(1 s). Insets expand the segments of the trace recorded when the light pulses were delivered. 
c: Trace from the same cell as in b, but with exposure to 10 μM GABA alone. d: Trace from 
the same cell as in b-c, but with exposure to 10 μM GABA + 300 μM propofol. e: Summary 
of results described in b-d. The left-hand trace shows the method used to obtain the 
numerical data shown at the right. The magnitude of the UV-to-blue transition was 
calculated as (B-UV1)/UV1; that of the blue-to-UV transition was calculated as (UV2-B)/
UV2. Here, UV1, B and UV2 are, respectively, the magnitude of the current evoked by the 
first UV flash, the blue flash and the second UV flash, as referenced to the pre-GABA 
current level. The number above each condition indicates the number of cells from which 
data were obtained. For the negative control experiments (i.e., those involving exposure to 
vehicle or propofol alone) in which no light-evoked current was detectable, current was 
measured for identical epochs at the terminations of the light pulses. Error bars represent the 
SEM. For both the blue-to-UV and the UV-to-blue transitions, the Kruskal-Wallis ANOVA 
on Ranks yielded p < 0.005 (H > 11, df = 2). Post-hoc statistical tests showed that results 
obtained with MPC088 treatment differed significantly from those obtained under either 
negative control condition (Mann-Whitney Rank-Sum Test: MPC088 vs. vehicle (blue-to-
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UV and UV-to-blue), p = 0.002; MPC088 vs. propofol (blue-to-UV and UV-to-blue), p = 
0.014; p values adjusted for multiple comparisons). f: Representative trace from a cell 
exposed to multiple UV/blue light flashes during application of GABA and MPC088.
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Figure 7. Effect of MPC088 photoactivation on action potential firing frequency in PNs
a: Representative data obtained by whole-cell current-clamp recording from a PN which 
was injected with 468 pA to elicit a high-frequency train of action potentials. During this 
current step, 10 μM GABA + 30 μM trans-dominant MPC088 were applied via pressure 
pipette for 10 s. The cell was then exposed for 1-s durations to UV light (UV1), then blue 
light, and then again with UV (UV2). The entire illustrated voltage vs. time trace occurs 
during application of GABA/MPC088. Below this trace is plotted the instantaneous firing 
frequency vs. time; the dashed line reflects the average firing frequency during the 1-s epoch 
that preceded the first UV exposure. b: Summary of results from experiments of the type 
shown in a. Average spike frequencies were obtained for each cell in each of five 1-s 
epochs, then normalized to the pre-GABA/MPC088 firing frequency (n = 8 cells from 4 
animals). Error bars here and in c represent the SEM. Repeated-measures ANOVA on the 
aggregate data yielded F(3,21) = 10.213, p < 0.001. Red asterisks above the purple and blue 
bars indicate significance of the average frequency in that epoch vs.the preceding epoch 
(e.g., the asterisk above the UV1 bar refers to significance of the average firing rate in the 
UV1 epoch vs. the GABA/MPC088 pre-UV epoch). Significance was determined from post-
hoc paired-sample t-tests corrected for multiple comparisons, which yielded p < 0.02. c: 
Summary of results from experiments similar to that described in a, but in which the cell 
was exposed only to the UV/Blue/UV flash sequence (i.e., no GABA/MPC088 applied). 
Data normalized to the average firing frequency during the 1-s period preceding the first UV 
flash (n = 7 cells from 3 animals). Repeated-measures ANOVA on the aggregate data 
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yielded F(3,18) = 3.057, p > 0.05. Three post-hoc statistical tests were then performed as 
described in b; none of these yielded significance at the uncorrected 0.05 level.
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Figure 8. Lack of agonist activity of MPC088 on PNs
a: Averages of 10 recordings from a PN exposed to multiple Blue/UV light flashes, in the 
presence of cis-dominant MPC088 (30 μM) in the external solution, before (black) and after 
(red) the addition of gabazine (30 μM). There was no exogenous GABA present in the 
tissue. b: Summary of results from 8 experiments (8 PNs) including that described in a. The 
data indicate the magnitude of an outward current. The temporal sequence of illumination 
differed among the experiments (e.g., only the cell in a received multiple blue/UV 
exposures), but the data plotted are the amplitudes from the blue to UV transition (in the 
case of the cell in a, this is the blue/UV transition from the first of the three exposures). 
Yellow-filled data points indicate results from the experiment in a. Each data point is the 
average obtained from 4-10 consecutive recordings. The light-evoked membrane current 
was significantly reduced by gabazine (Wilcoxon Signed Rank Test, p=0.008). Error bars 
represent the SEM.
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